Production of Lentiviral Vectors

Details for Australian Patent Application No. 2008215979 (hide)

Owner Ark Therapeutics Ltd.

Inventors Yla-Herttuala, Seppo; Airenne, Kari J.; Lesch, Hanna P.

Agent Wrays

Pub. Number AU-B-2008215979

PCT Pub. Number WO2008/099148

Priority 0702695.8 12.02.07 GB

Filing date 11 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 8 March 2012

International Classifications

C12N 15/79 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099148 Priority application(s): WO2008/099148

8 March 2012 Application Accepted

  Published as AU-B-2008215979

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215980-Method for incorporating proteins into lentivirus vectors

2008215976-Pyrazole derivatives as 11-beta-HSD1 inhibitors